Smallcap Recap Archives

April, 2005: EntreMed ... IPIX ... Supercom ... Sangamo BioSciences ...
Peregrine Pharmaceuticals ... Global ePoint ... RAE Systems
-------------------------------------------------------------------------

. . . New Contracts. New Listing. WPCS International (Nasdaq: WPCS), an engineering company that focuses on the implementation requirements of wireless technology and specialty communications systems, was awarded approximately $3.3 million in new contracts for its wireless services. New contracts include projects for U.S. Cellular, Nextel, T-Mobile, New Jersey State Police, Taj Mahal Casino-Hotel, General Electric and Lockheed Martin.The company, which had been trading on the OTC Bulletin Board, was recently approved for listing on the NASDAQ Small Cap Market.

. . . Taking PC portability to another level. You're traveling, but don't have your laptop with you. Wouldn't it be convenient to go to a cyber café and pull up and work on a copy of your PC with your Outlook Express, data files and internet favorites. And when you're done, no trace of your information is left behind and all changes will be automatically synchronized on your main PC. Now you can, using a DiskOnKey(R) device, a technology made possible by an agreement between M-Systems (NASDAQ:FLSH), a developer of USB flash drives, and PowerHouse Technologies Group (OTCBB:PWHT), a provider of mobile computing software.

. . . Promising arthritis treatment - EntreMed (Nasdaq: ENMD) announced preclinical data that showed promising results for 2ME2 in the treatment of rheumatoid arthritis. Oral treatment with 2ME2 resulted in a dose-dependent decrease in the severity of arthritic disease. A decrease in clinical symptoms with 2ME2 administration was accompanied by a marked inhibition of tissue and joint damage that are hallmarks of rheumatoid arthritis. EntreMed is currently evaluating 2ME2 formulations (Panzem® Capsules and Panzem® NCD) in Phase I and II clinical oncology studies, as well as preclinical studies of 2ME2 in inflammatory diseases such as rheumatoid arthritis.

. . . 360-degree surveillance - IPIX (NASDAQ:IPIX), a supplier of 360-degree, immersive imaging cameras and technologies is teaming with new video surveillance partners to provide more panoramic threat detection. Recent partnerships include surveillance software manufacturers VistaScape Security Systems and ObjectVideo. IPIX's immersive imaging technology provides security personnel with a more complete, real-time view of a security area, offers a greater level of functionality and reduces the number of necessary cameras, infrastructure and installation costs.

. . . Who do you let into a disaster? There's been a good deal of talk in homeland security circles about equipping first responders with the tools they need to respond to disasters. But there is another question involved. How can you be sure who is really authorized personnel for such situations and who is not? That's where the Smart Disaster Site Management System, a comprehensive, end-to-end solution for access control and personnel tracking comes in. The city of Columbus, Ohio has selected Smart Disaster Site Management System from Supercom Ltd (OTC Bulletin Board: SPCBF.OB; Euronext:SUP) to improve access control in disaster recovery operations. It is expected that smart cards containing fingerprint biometrics and biographical data will be issued to first responder emergency personnel as well as to other qualified personnel. Supercom offers a wide range of standard and customized smart-card-based solutions for physical and logical security, education, corrections facilities and air & seaports.

. . . Editing Genes - It seems that the some of the human genome's "errors" may soon be able to be corrected with new gene editing technology. Sangamo BioSciences (Nasdaq: SGMO) has announced the results of a study demonstrating that its zinc finger DNA-binding protein technology achieved "highly efficient, permanent correction of a disease-causing gene in primary human cells." ZFN Technology facilitated the modification of a DNA sequence at the site of a mutation in the gene. The study also indicated that gene correction was permanent.

. . . Preclinical Promise - Pre-clinical data demonstrated that Tarvacin(TM) from Peregrine Pharmaceuticals (Nasdaq: PPHM), and related Anti-Phospholipid Therapy agents, have anti-viral therapy which may have far reaching implications for the treatment of infectious disease. According to Dr. Philip Thorpe, professor of pharmacology at UT Southwestern, "since Tarvacin(TM) targets a basic, universal property of enveloped viruses that is host-derived and independent of the viral genome, it may be effective against a broad spectrum of enveloped viruses."

. View from the cockpit - Global ePoint (Nasdaq:GEPT) will supply GE Capital Aviation Service with video surveillance systems for cockpits. Global's Airworks Cockpit Door Surveillance System will be installed on eight AirBus A320 aircraft. The Airworks Cockpit Door Surveillance System provides pilots and crew members with a state-of-the-art tool to assess potential emergency situations. Global ePoint's growth strategy focuses on the design, manufacturing, sales and distribution of digital video surveillance systems for the law enforcement, military, aviation and homeland security markets.

. . . New Products. New Coverage. Morgan Keegan initiated coverage of RAE Systems (AMEX:RAE) with an outperform rating. RAE is a global developer and manufacturer of rapidly deployable, multi-sensor chemical detection monitors and networks for homeland security and industrial applications. In the current quarter, the company has introduced a number of products, including the HazRAE Handheld Wireless Decision Support System, PlumeRAE Integrated Decision Support System, and GammaRAE II Low-Cost Gamma Radiation Detector.